GLP-1 receptor agonist medications (examples include semaglutide marketed as Ozempic and Wegovy, tirzepatide marketed as Mounjaro, and other agents such as Zepbound) mimic the gut hormone glucagon-like peptide-1 (GLP-1) and act by slowing digestion, reducing appetite, and helping to control blood sugar after meals.
January 01, 2025
high
descriptive
Mechanism of action and metabolic effects of GLP-1 receptor agonist medications used for weight loss and glycemic control.